Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Barr Group" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Barr Group for you to read. Along with our medical data and news we also list Barr Group Clinical Trials, which are updated daily. BioPortfolio also has a large database of Barr Group Companies for you to search.
GRANGER, Iowa, Aug. 6, 2018 /PRNewswire/ -- Barr-Nunn Transportation, the 13 year Certified Top Pay Carrier, is at it again with more pay raises for Read more...
Trump's attorney general pick: I will not be bullied Sky NewsWilliam Barr: 'I will not be bullied,' Trump nominee says BBC NewsTrump's attorney general pick says Mueller report may not be made public The GuardianDemocratic senators expose William Barr's cluelessness on criminal justice The Washington PostIf Democrats oppose Barr, they'll oppose anyone Trump nominates -- He deserves bipartisan ...
NewsEpstein-Barr Virus (EBV) doesn't directly cause cancer, but infection with this common herpes virus brings an increased risk of some cancers.
Jodie Barr, DO, discusses the evolution of treatment of patients with neuroendocrine tumors and the need for biomarkers.
“Scientists have amassed the strongest evidence yet that the Zika virus can cause the serious neurological condition Guillain-Barré syndrome,” The Guardian reports.
Guillain-Barré syndrome associated with Zika virus is similar to non-Zika virus cases in terms of severity of illness and prognosis around long-term recovery and disability.
Atara Biotherapeutics (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today presented results indicating that tab-cel® (tabelecleucel) was generally well tolerated with responses for patients with Epstein-Barr virus-associated leiomyosarcoma (EBV+ LMS). As quoted in the press rele...
(Johns Hopkins Medicine) New research from Johns Hopkins Medicine and Sheppard Pratt Health System shows that people in the study with schizophrenia also have higher levels of antibodies against the Epstein-Barr virus (EBV), a herpes virus that causes infectious mononucleosis, so-called mono.
Tokyo Medical and Dental University study shows that ruxolitinib-induced inhibition of STAT3 activity blocks survival and reduces pro-inflammatory cytokine production in Epstein-Barr virus (EBV)-infected clonally proliferating T- or NK-cells in Chronic active Epstein-Barr virus infection.
$ATRA Presents Positive Efficacy and Safety Results for Patients with Epstein-Barr Virus-Associated Leiomyosarcoma (EBV+ LMS) #ESMO18 https://globenewswire.com/news-release/2018/12/15/1667575/0/en/Atara-Biotherapeutics-Presents-Positive-Efficacy-and-Safet
$ATRA Presents Positive Efficacy and Safety Results for Patients with Epstein-Barr Virus-Associated Leiomyosarcoma (EBV+ LMS) #ESMO18 https://globenewswire.com/news-release/2018/12/15/1667575/0/en/Atara-Biotherapeutics-Presents-Positive-Efficacy-and-Safety-Results-for-Patients-with-Epstein-Barr-Virus-Associated-Leiomyosarcoma-EBV-LMS.html …
Second EBV‑associated solid tumor with encouraging responses to tab-cel®Tab-cel® safety appears consistent with a favorable risk profile and previous observationsResults were presented today in an oral session at the European Society for Medical Oncology Immuno-Oncology Congress 2018 SOUTH SAN FRANCISCO, Calif., Dec. 15, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), ...
Atara Biotherapeutics Announces Publication of Phase 1 Study Demonstrating Clinical Improvement in Progressive Multiple Sclerosis Patients Treated with ATA190, an Autologous Epstein-Barr Virus (EBV)-Specific T-Cell Immunotherapy
SOUTH SAN FRANCISCO, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today announced that results of a Phase 1 clinical study conducted by the Company's collaborating investigators at QIMR Ber
New research draws a link between infection with the Epstein-Barr virus and schizophrenia, though cause and effect relationships remain unclear.
What is the most common risk factor for Guillain-Barré Syndrome? Plus 4 other quick questions to test your knowledge.
Did Alexander the Great meet his demise more than 2,300 years ago because of the neurological disorder Guillain-Barré Syndrome (GBS)?
Technavio analysts forecast the global Guillain-Barré syndrome treatment market to grow at a CAGR of over 5% during the forecast period, according to their latest market research report. The growth momentum of the market is expected to accelerate in the year-over-year growth. This press release features multimedia. View the full release here: https://www....
Human SH2D1A mutations resulting in X-linked lymphoproliferative syndrome type 1 are associated with a unique susceptibility to the Epstein-Barr virus, which may lead to fatal infectious mononucleosis.
A simple enhanced ultrasound scan of the kidney is more accurate than computed tomography (CT) and magnetic resonance (MR) imaging in predicting whether suspicious masses are cancerous -- and can eliminate the need for unnecessary biopsies and surgeries, according to a 10-year study presented today at an international medical conference in Chicago. ...
Cullinan Oncology LLC licensed exclusive global rights to develop and commercialize a candidate discovered by the Wistar Inst...
EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 28.11.2018 / 17:35 Under the following link, you will find a press release of the Zur Rose Group. https://zurrosegroup.com/websites/zurrosegroup/English/2015/acquisition-medpex.html End of Corporate News ...
EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 29.11.2018 / 07:00 Under the following link, you will find a press release of the Zur Rose Group. https://zurrosegroup.com/websites/zurrosegroup/English/2015/acquisition-medpex.html End of Corporate News ...